| Jennifer Anne Dixon, | |
|
124a N Pershing Dr, Brookfield, MO 64628-2736 | |
| (660) 258-2159 | |
| (660) 258-2190 |
| Full Name | Jennifer Anne Dixon |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 124a N Pershing Dr, Brookfield, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295875045 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 2005001682 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Anne Dixon, 907 N Mulberry St, Marceline, MO 64658-9114 Ph: (660) 376-4139 | Jennifer Anne Dixon, 124a N Pershing Dr, Brookfield, MO 64628-2736 Ph: (660) 258-2159 |
News Archive
People with early Alzheimer's disease who had better fitness ratings had less atrophy in key brain areas associated with memory, according to research reported today at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD 2008) in Chicago.
New research confirms that successful pregnancies are common for female liver transplant recipients. The study appearing in the June issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, found miscarriage risk was lower and the live birth rate higher among women following liver transplantation than in the general U.S. population.
Two years after the reauthorization and expansion of the Children's Health Insurance Program, a new Commonwealth Fund state-by-state scorecard evaluating how the health care system is working for children finds that federal and state action on behalf of children has helped preserve, and even expand, health coverage for this group, despite the severe recession.
An attentive, nurturing mother may be able to help her children better resist the temptations of drug use later in life, according to a study involving the University of Adelaide.
The European Society for Blood and Marrow Transplantation (EBMT), Europe's collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced today the results of the phase III RACE trial during EBMTs virtual 46th Annual Meeting. Preliminary data show that adding Eltrombopag to standard immunosuppressive treatment is safe and increases response rates in patients with Severe Aplastic Anaemia.
› Verified 8 days ago